PT771817E - Mono-esteres de oleato de estrogenos para o tratamento da obesidade e/ou excesso de peso - Google Patents
Mono-esteres de oleato de estrogenos para o tratamento da obesidade e/ou excesso de pesoInfo
- Publication number
- PT771817E PT771817E PT96500140T PT96500140T PT771817E PT 771817 E PT771817 E PT 771817E PT 96500140 T PT96500140 T PT 96500140T PT 96500140 T PT96500140 T PT 96500140T PT 771817 E PT771817 E PT 771817E
- Authority
- PT
- Portugal
- Prior art keywords
- estrogen
- obesity
- treatment
- group
- estrone
- Prior art date
Links
- 208000008589 Obesity Diseases 0.000 title abstract 2
- 229940011871 estrogen Drugs 0.000 title abstract 2
- 239000000262 estrogen Substances 0.000 title abstract 2
- 235000020824 obesity Nutrition 0.000 title abstract 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical class CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 title abstract 2
- DNXHEGUUPJUMQT-UHFFFAOYSA-N (+)-estrone Natural products OC1=CC=C2C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 DNXHEGUUPJUMQT-UHFFFAOYSA-N 0.000 abstract 1
- PROQIPRRNZUXQM-UHFFFAOYSA-N (16alpha,17betaOH)-Estra-1,3,5(10)-triene-3,16,17-triol Natural products OC1=CC=C2C3CCC(C)(C(C(O)C4)O)C4C3CCC2=C1 PROQIPRRNZUXQM-UHFFFAOYSA-N 0.000 abstract 1
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 abstract 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 abstract 1
- DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 abstract 1
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 abstract 1
- 102000004895 Lipoproteins Human genes 0.000 abstract 1
- 108090001030 Lipoproteins Proteins 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 206010033307 Overweight Diseases 0.000 abstract 1
- 235000021314 Palmitic acid Nutrition 0.000 abstract 1
- 235000021319 Palmitoleic acid Nutrition 0.000 abstract 1
- 241000700159 Rattus Species 0.000 abstract 1
- 235000021355 Stearic acid Nutrition 0.000 abstract 1
- IMIPDPVHGGHVNH-YWVHRCQQSA-N [(8r,9s,13s,14s)-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6h-cyclopenta[a]phenanthren-3-yl] (z)-octadec-9-enoate Chemical compound C1C[C@]2(C)C(=O)CC[C@H]2[C@@H]2CCC3=CC(OC(=O)CCCCCCC\C=C/CCCCCCCC)=CC=C3[C@H]21 IMIPDPVHGGHVNH-YWVHRCQQSA-N 0.000 abstract 1
- 210000000577 adipose tissue Anatomy 0.000 abstract 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 abstract 1
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical class CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 abstract 1
- 235000021342 arachidonic acid Nutrition 0.000 abstract 1
- 210000004556 brain Anatomy 0.000 abstract 1
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 1
- RGLYKWWBQGJZGM-ISLYRVAYSA-N diethylstilbestrol Chemical compound C=1C=C(O)C=CC=1C(/CC)=C(\CC)C1=CC=C(O)C=C1 RGLYKWWBQGJZGM-ISLYRVAYSA-N 0.000 abstract 1
- 229960000452 diethylstilbestrol Drugs 0.000 abstract 1
- 229960005309 estradiol Drugs 0.000 abstract 1
- 229930182833 estradiol Natural products 0.000 abstract 1
- 229960001348 estriol Drugs 0.000 abstract 1
- PROQIPRRNZUXQM-ZXXIGWHRSA-N estriol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H]([C@H](O)C4)O)[C@@H]4[C@@H]3CCC2=C1 PROQIPRRNZUXQM-ZXXIGWHRSA-N 0.000 abstract 1
- 229960003399 estrone Drugs 0.000 abstract 1
- 229960002568 ethinylestradiol Drugs 0.000 abstract 1
- 229930195729 fatty acid Natural products 0.000 abstract 1
- 239000000194 fatty acid Substances 0.000 abstract 1
- 150000004665 fatty acids Chemical class 0.000 abstract 1
- 238000010253 intravenous injection Methods 0.000 abstract 1
- 235000020778 linoleic acid Nutrition 0.000 abstract 1
- 239000002502 liposome Substances 0.000 abstract 1
- 231100000053 low toxicity Toxicity 0.000 abstract 1
- 230000003278 mimic effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 235000021313 oleic acid Nutrition 0.000 abstract 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N palmitic acid group Chemical group C(CCCCCCCCCCCCCCC)(=O)O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 abstract 1
- 239000013585 weight reducing agent Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/52—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
- C07C69/533—Monocarboxylic acid esters having only one carbon-to-carbon double bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/017—Esters of hydroxy compounds having the esterified hydroxy group bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
- C07C69/22—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety
- C07C69/28—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety esterified with dihydroxylic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/52—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
- C07C69/533—Monocarboxylic acid esters having only one carbon-to-carbon double bond
- C07C69/58—Esters of straight chain acids with eighteen carbon atoms in the acid moiety
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/52—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
- C07C69/587—Monocarboxylic acid esters having at least two carbon-to-carbon double bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
- C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES9502101 | 1995-10-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT771817E true PT771817E (pt) | 2003-06-30 |
Family
ID=8291993
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT96500140T PT771817E (pt) | 1995-10-30 | 1996-10-28 | Mono-esteres de oleato de estrogenos para o tratamento da obesidade e/ou excesso de peso |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US5798348A (pt) |
| EP (1) | EP0771817B1 (pt) |
| AT (1) | ATE235505T1 (pt) |
| DE (1) | DE69626927T2 (pt) |
| DK (1) | DK0771817T3 (pt) |
| ES (1) | ES2192221T3 (pt) |
| PT (1) | PT771817E (pt) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2321455A (en) | 1997-01-24 | 1998-07-29 | Norsk Hydro As | Lipophilic derivatives of biologically active compounds |
| AU4701299A (en) * | 1998-06-23 | 2000-01-10 | Stuart R. Adler | Therapeutic applications of estrogenic carboxylic acids |
| WO2000050067A1 (en) * | 1999-02-26 | 2000-08-31 | Saltech I Göteborg Ab | Method and composition for the regulation of hepatic and extrahepatic production of insulin-like growth factor-1 |
| CA2669753C (en) | 1999-09-30 | 2012-06-26 | Hollis-Eden Pharmaceuticals, Inc. | Therapeutic treatment of androgen receptor driven conditions |
| US7025984B1 (en) * | 2000-06-26 | 2006-04-11 | The Procter & Gamble Company | Compositions and methods for body weight management |
| AU2005242170B2 (en) * | 2000-06-26 | 2008-12-18 | The Procter & Gamble Company | Compositions and methods for body weight management |
| AU2002244247B2 (en) | 2001-03-01 | 2007-12-13 | Harbor Biosciences, Inc. | Use of certain steroids for treatment of blood cell deficiencies |
| ES2173049B1 (es) * | 2001-03-28 | 2004-01-16 | Oleoyl Estrone Developments S | Monoester de acido graso y estrogeno como agente antidiabetico e hipolipemiante. |
| US6635015B2 (en) * | 2001-04-20 | 2003-10-21 | The Procter & Gamble Company | Body weight management system |
| US7125568B2 (en) | 2001-08-23 | 2006-10-24 | Sung Michael T | Lipophilic drug compositions |
| WO2003018529A1 (en) * | 2001-08-24 | 2003-03-06 | Girouard Michael P | Monounsaturated fatty acids of at least 20 carbon atoms and perhydrocyclopentanophenanthrene nucleus combination molecules and their use as weight-loss agents |
| US20040157816A1 (en) * | 2002-08-26 | 2004-08-12 | Girouard Michael P. | Monounsaturated fatty acids and perhydrocyclopentanophenanthrene nucleus combination molecules, and their precursors, and the use of all of these as weight-loss agents |
| ES2186576B1 (es) * | 2001-10-11 | 2004-09-16 | Universitat De Les Illes Balears | Acido 2-hidroxioleico para utilizar como medicamento. |
| CA2543393A1 (en) * | 2002-11-20 | 2004-06-03 | Michael P. Girouard | Combination of monounsaturated fatty acids and estrogen, and their use |
| US7731947B2 (en) | 2003-11-17 | 2010-06-08 | Intarcia Therapeutics, Inc. | Composition and dosage form comprising an interferon particle formulation and suspending vehicle |
| CA2515368A1 (en) | 2003-02-13 | 2004-08-26 | Luciano Rossetti | Regulation of food intake and glucose production by modulation of long-chain fatty acyl-coa levels in the hypothalamus |
| CA2436650A1 (en) * | 2003-08-06 | 2005-02-06 | Naturia Inc. | Conjugated linolenic acid (clnatm) compositions: synthesis, purification and uses |
| WO2006110172A2 (en) | 2004-09-29 | 2006-10-19 | Hollis-Eden Pharmaceuticals.Inc. | Steroid analogs and characterization and treatment methods |
| US20060084637A1 (en) * | 2004-10-18 | 2006-04-20 | Maria Alemany | Methods of using fatty-acid esters of estrogens and thermogenic compounds for reducing the body weight of a mammal and compositions containing the same |
| US20060084636A1 (en) * | 2004-10-18 | 2006-04-20 | Maria Alemany | Methods of using fatty-acid esters of estrogens and serotonin reuptake inhibiting compounds for reducing the body weight of a mammal and compositions containing the same |
| US11246913B2 (en) | 2005-02-03 | 2022-02-15 | Intarcia Therapeutics, Inc. | Suspension formulation comprising an insulinotropic peptide |
| WO2006083761A2 (en) | 2005-02-03 | 2006-08-10 | Alza Corporation | Solvent/polymer solutions as suspension vehicles |
| US7528791B2 (en) * | 2005-08-08 | 2009-05-05 | Wistron Neweb Corporation | Antenna structure having a feed element formed on an opposite surface of a substrate from a ground portion and a radiating element |
| WO2007140416A2 (en) | 2006-05-30 | 2007-12-06 | Intarcia Therapeutics, Inc. | Two-piece, internal-channel osmotic delivery system flow modulator |
| WO2008147373A2 (en) * | 2006-06-26 | 2008-12-04 | Manhattan Pharmaceuticals, Inc. | Methods and compositions for reducing body weight using an estrogen fatty ester in an oil |
| PT2359808E (pt) | 2006-08-09 | 2013-08-28 | Intarcia Therapeutics Inc | Sistemas de entrega osmótica e montagens de pistão |
| ES2302449B1 (es) * | 2006-10-30 | 2009-06-12 | Oleoyl-Estrone Developments, S.L. | Monoesteres de estrogenos con acido linoleico conjugado y usos de los mismos. |
| ES2402172T3 (es) | 2007-04-23 | 2013-04-29 | Intarcia Therapeutics, Inc | Formulación en suspensión de péptidos insulinotrópicos y usos de los mismos |
| EP2085089A1 (en) * | 2008-02-01 | 2009-08-05 | KTB-Tumorforschungs GmbH | Phospholipids Containing omega-3-Fatty Acids for the Treatment of Overweight, Obesity and Addictive Behavior |
| WO2009102467A2 (en) | 2008-02-13 | 2009-08-20 | Intarcia Therapeutics, Inc. | Devices, formulations, and methods for delivery of multiple beneficial agents |
| EP3735944A1 (en) | 2009-09-28 | 2020-11-11 | Intarcia Therapeutics, Inc. | Rapid establishment and/or termination of substantial steady-state drug delivery |
| US20120208755A1 (en) | 2011-02-16 | 2012-08-16 | Intarcia Therapeutics, Inc. | Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers |
| WO2013102207A1 (en) * | 2011-12-30 | 2013-07-04 | Rosscreening, Inc. | Estrogen receptor modulators for reducing body weight |
| US9889085B1 (en) | 2014-09-30 | 2018-02-13 | Intarcia Therapeutics, Inc. | Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c |
| KR102650751B1 (ko) | 2015-06-03 | 2024-03-22 | 인타르시아 세라퓨틱스 인코포레이티드 | 임플란트 배치 및 제거 시스템들 |
| CN109310743A (zh) | 2016-05-16 | 2019-02-05 | 因塔西亚制药公司 | 胰高血糖素受体选择性多肽及其使用方法 |
| USD860451S1 (en) | 2016-06-02 | 2019-09-17 | Intarcia Therapeutics, Inc. | Implant removal tool |
| USD840030S1 (en) | 2016-06-02 | 2019-02-05 | Intarcia Therapeutics, Inc. | Implant placement guide |
| AU2018206539A1 (en) | 2017-01-03 | 2019-07-18 | Intarcia Therapeutics, Inc. | Methods comprising continuous administration of a GLP-1 receptor agonist and co-administration of a drug |
| US10836788B2 (en) | 2019-02-05 | 2020-11-17 | SD Chem, Inc. | Aqueous suspension compositions, formulations, and water dispersible dry compositions comprising 16alpha-bromo-3beta-hydroxy-5alpha-androstan-17-ketone and hydrates, derivatives, and analogs thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2265976A (en) * | 1937-10-25 | 1941-12-09 | Schering Corp | Tertiary alcohols of the estrane series and their derivatives and a process for their manufacture |
| GB531178A (en) * | 1938-07-02 | 1940-12-31 | Chem Ind Basel | Manufacture of new esters of the oxy-stilbene series |
| JPH0610127B2 (ja) * | 1985-02-09 | 1994-02-09 | ライオン株式会社 | 養毛料 |
| US4617298A (en) * | 1985-10-22 | 1986-10-14 | University Of Florida | Method and compositions for weight control |
-
1996
- 1996-10-28 PT PT96500140T patent/PT771817E/pt unknown
- 1996-10-28 EP EP96500140A patent/EP0771817B1/en not_active Expired - Lifetime
- 1996-10-28 AT AT96500140T patent/ATE235505T1/de not_active IP Right Cessation
- 1996-10-28 DE DE69626927T patent/DE69626927T2/de not_active Expired - Lifetime
- 1996-10-28 ES ES96500140T patent/ES2192221T3/es not_active Expired - Lifetime
- 1996-10-28 DK DK96500140T patent/DK0771817T3/da active
- 1996-10-30 US US08/739,165 patent/US5798348A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ES2192221T3 (es) | 2003-10-01 |
| US5798348A (en) | 1998-08-25 |
| EP0771817B1 (en) | 2003-03-26 |
| ATE235505T1 (de) | 2003-04-15 |
| EP0771817A2 (en) | 1997-05-07 |
| EP0771817A3 (en) | 1999-04-14 |
| DE69626927T2 (de) | 2003-11-20 |
| DK0771817T3 (da) | 2003-07-28 |
| DE69626927D1 (de) | 2003-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT771817E (pt) | Mono-esteres de oleato de estrogenos para o tratamento da obesidade e/ou excesso de peso | |
| McMurchie et al. | Incorporation and effects of dietary eicosapentaenoate (20: 5 (n− 3)) on plasma and erythrocyte lipids of the marmoset following dietary supplementation with differing levels of linoleic acid | |
| Zampolli et al. | Contrasting effect of fish oil supplementation on the development of atherosclerosis in murine models | |
| Wargovich et al. | Calcium inhibits the damaging and compensatory proliferative effects of fatty acids on mouse colon epithelium | |
| Bourre et al. | High dietary fish oil alters the brain polyunsaturated fatty acid composition | |
| BR9803195A (pt) | Produto alimentìcio à base de gordura,e, pasta de gordura amarela de espalhar. | |
| BR0307101A (pt) | Fracionamento de ésteres de fitosterol em óleo | |
| ES2074734T5 (es) | Utilizacion de composiciones a base de alcoholes grasos, para la preparacion de emulsiones; procedimiento de preparacion de emulsiones y emulsiones asi obtenidas. | |
| AU2671292A (en) | Use of an emulsion to prepare an intravenously administered medicament for treating skin diseases | |
| EP1072249A3 (de) | Kosmetische und dermatologische Zubereitungen auf der Grundlage von O/W-Emulsionen | |
| KR960010832B1 (ko) | 필수지방산 합성물(Essential Fatty Acid Compositins) | |
| Williams | Dietary interventions affecting chylomicron and chylomicron remnant clearance | |
| Williams et al. | Effects of dietary fat level on pantothenate depletion and liver fatty acid composition in the rat | |
| ATE93722T1 (de) | Omega-3-fettsaeurenhaltige fettemulsion zur endotrachealen applikation, ihre herstellung und anwendung. | |
| ATE193006T1 (de) | Verfahren zur stabilisation der polyungesättigten fettsäuren und verwendung dieser stabilisierten produkten in therapie und in kosmetologie | |
| Kiitchevsky et al. | Serum and liver lipids of rats fed cocoa butter, corn oil, palm kernel oil, coconut oil and cholesterol | |
| Larue et al. | Effect of the removal of olfactory bulbs upon hyperphagia and obesity induced in rats by VMH lesion | |
| US5484611A (en) | Method of producing a fatty acid | |
| Leaf et al. | Experimental studies on antiarrhythmic and antiseizure effects of polyunsaturated fatty acids in excitable tissues | |
| WO2004045560A3 (en) | Combination of monounsaturated fatty acids and estogen, and their use | |
| KR910005872A (ko) | 간염 예방 치료제 | |
| Peterson et al. | Effects of dietary sterols and sterol esters on plasma and liver cholesterol in the chick | |
| KR920021151A (ko) | 면역억제특성을 갖는 약제학적 조성물을 제조하기 위한 인지질 유도체의 용도 | |
| RU2052947C1 (ru) | Масложировой продукт, имеющий иммуностимулирующие свойства | |
| Craig et al. | Nutritional properties of Canadian canbra oil |